Regulation of p53 protein function through alterations in protein-folding pathways

被引:51
作者
Hupp, TR [1 ]
机构
[1] Univ Dundee, Dept Mol Oncol, Dundee Canc Res Inst, Dundee DD1 9SY, Scotland
关键词
p53; heat shock proteins; phosphorylation; protein folding; oligomerization;
D O I
10.1007/s000180050272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumour suppressor protein p53 is a stress-activated transcription factor whose activity is required for regulating the cellular response to stress and damage. The biochemical activity of p53 as a transcription factor can be regulated by partner proteins affecting stability, nuclear transport, signalling pathways modulating phosphorylation and interactions with components of the transcriptional machinery. The key structural determinants of p53 protein that drive sequence-specific DNA binding include the core specific DNA-binding domain and the tetramerization domain. Flanking these domains are more evolutionarily divergent carboxy- and amino-terminal regulatory motifs that further modulate tetramerization and sequence-specific transactivation. This review will mainly focus on the mechanisms whereby the tetramerization domain modulates sequence-specific DNA binding and how missense point mutations in p53 protein and the activity of molecular chaperones may lead to unfolding of mutant p53 tetramers in human tumours.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 77 条
[1]   Depletion of p185(erbB2), Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity [J].
An, WG ;
Schnur, RC ;
Neckers, L ;
Blagosklonny, MV .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (01) :60-64
[2]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[3]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[4]   Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90 [J].
Blagosklonny, MV ;
Toretsky, J ;
Bohen, S ;
Neckers, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8379-8383
[5]  
BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933
[6]   Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[7]   Correcting temperature-sensitive protein folding defects [J].
Brown, CR ;
HongBrown, LQ ;
Welch, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1432-1444
[8]   INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].
BUCKBINDER, L ;
TALBOTT, R ;
VELASCOMIGUEL, S ;
TAKENAKA, I ;
FAHA, B ;
SEIZINGER, BR ;
KLEY, N .
NATURE, 1995, 377 (6550) :646-649
[9]   Thermodynamic stability of wild-type and mutant p53 core domain [J].
Bullock, AN ;
Henckel, J ;
DeDecker, BS ;
Johnson, CM ;
Nikolova, PV ;
Proctor, MR ;
Lane, DP ;
Fersht, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14338-14342
[10]   REFINED SOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF THE TUMOR-SUPPRESSOR P53 [J].
CLORE, GM ;
ERNST, J ;
CLUBB, R ;
OMICHINSKI, JG ;
KENNEDY, WMP ;
SAKAGUCHI, K ;
APPELLA, E ;
GRONENBORN, AM .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (04) :321-333